During the past decade, Sahlgrenska University Hospital/ Östra conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sahlgrenska University Hospital/ Östra" #1 sponsor was "Sahlgrenska University Hospital, Sweden" with 8 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Göteborg University" with 2 trials sponsored, "Vastra Gotaland Region" with 2 trials sponsored and "Niklas Nielsen" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sahlgrenska University Hospital/ Östra" #1 collaborator was "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 2 trials as a collaborator, "Göteborg University" with 2 trials as a collaborator, "Lund University" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator and "Arvid Carlsson Research AB" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Sahlgrenska University Hospital/ Östra" are "COVID-19" (2 trials), "Colorectal Neoplasm" (2 trials), "Out-of-hospital Cardiac Arrest" (2 trials), "Anesthesia" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Sahlgrenska University Hospital/ Östra" in a lesser frequency.

Most popular intervention types in "Sahlgrenska University Hospital/ Östra" are "Other" (5 trials), "Drug" (4 trials), "Procedure" (3 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Remdesivir" (2 trials), "Standard of Care" (2 trials), "Abbreviated MRI of the liver/abdomen" (1 trials), "Bupivacain" (1 trials) and "Circular incision" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sahlgrenska University Hospital/ Östra" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sahlgrenska University Hospital/ Östra". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Sahlgrenska University Hospital/ Östra, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sahlgrenska University Hospital/ Östra, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".